Executive Order on Essential Medicines and Medical Countermeasures Domestic Production

Executive Order 13944 was signed on August 6, 2020, directing federal agencies to prioritize domestic production of essential medicines, medical countermeasures, and critical inputs needed for public health emergencies. The order established requirements for federal procurement preferences and directed the Department of Health and Human Services and Department of Defense to assess supply chain vulnerabilities and develop strategies to increase domestic manufacturing capacity. Confirmed effects included increased federal contracting focus on domestic suppliers and initiation of supply chain assessments, though full implementation of domestic production expansion occurred over subsequent months.